The challenge of testing chemicals for potential carcinogenicity using multiple short-term assays: An analysis of a proposed test battery for hair dyes

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 633, Issue 1, 2007, Pages 55-66

  Rosenkranz, Herbert S ^a   Cunningham, Suzanne L ^a   Mermelstein, Robert ^a   Cunningham, Albert R ^b  

^a University of Louisville ^*

^b University of Louisville School of Medicine   (United States)

Author keywords

Carcinogenicity; Hair dyes; Short term assays; Test battery

Indexed keywords

CARCINOGEN; HAIR DYE;

ARTICLE; BAYES THEOREM; CARCINOGEN TESTING; CARCINOGENICITY; IN VITRO SELECTION; IN VIVO STUDY; MUTAGEN TESTING; MUTAGENICITY; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT;

ANIMALS; BIOLOGICAL ASSAY; CARCINOGENICITY TESTS; CELLS, CULTURED; HAIR DYES; LYMPHOMA; MICE; MICRONUCLEUS TESTS; MUTAGENICITY TESTS; PREDICTIVE VALUE OF TESTS; SALMONELLA TYPHIMURIUM; SENSITIVITY AND SPECIFICITY;

EID: 34547135708     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2007.05.008     Document Type: Article

References (51)

1. Gago-Dominguez M., Chan K.K., Ross R.K., and Yu M.C. Permanent hair dyes and bladder cancer risk. Int. J. Cancer 94 (2001) 905-906
2. Gago-Dominguez M., Castelao J.E., Yuan J.-M., Yu M.C., and Ross R.K. Use of permanent hair dyes and bladder-cancer risk. Int. J. Cancer 91 (2001) 575-579
3. M. Gago-Dominguez, D.A. Bell, M.A. Watson, J.-M. Yuan, J.E. Castelao, D.W. Hein, C. Chan, G.A., R.K. Ross, M.C. Yu, Permanent hair dyes and bladder cancer: risk modification by cytochrome P4501A2 and N-acetyltransfereases 1 and 2, Carcinogenesis 24 (2003) 483-489.
4. Yu M.C., Skipper P.L., Tannenbaum S.R., Chan K.K., and Ross R.K. Arylamine exposures and bladder cancer risk. Mutat. Res. 506-507 (2002) 21-28
5. Hein D.W. Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutat. Res. 506-507 (2002) 65-77
6. Turesky R.J., Freeman J.P., Holland R.D., Nestorick D.M., Miller D.W., Ratnasinghe D.L., and Kadlubar F.F. Identification of aminobiphenyl derivatives in commercial hair dyes. Chem. Res. Toxicol. 16 (2003) 1162-1173
7. Skipper P.L., Tannenbaum S.R., Ross R.K., and Yu M.C. Nonsmoking-related arylamine exposure and bladder cancer risk. Cancer Epidemiol. Biomarkers Prev. 12 (2003) 503-507
8. SCCNFP, Updated Recommended Strategy for Testing Hair Dyes for Their Potential Genotoxicity/Mutagenicity/Carcinogenicity, 2003, http://europa.eu.int/comm/food/fs/sc/sccp/out224_en.pdf.
9. Reisch M.S. Flush with color: continuing progress in hair dye chemistry satisfies diverse desires of young and old. Chem. Eng. News 81 (2003) 25-27
10. Ennever F.K., Noonan T.J., and Rosenkranz H.S. The predictivity of animal bioassays and short-term genotoxicity tests for carcinogenicity and non-carcinogenicity to humans. Mutagenesis 2 (1987) 73-78
11. Bartsch H., and Malaveille C. Prevalence of genotoxic chemicals among animal and human carcinogens evaluated in the IARC monograph series. Cell Biol. Toxic. 5 (1989) 115-127
12. Shelby M.D. The genetic toxicity of human carcinogens and its implications. Mutat. Res. 204 (1988) 3-15
13. Ashby J., and Morrod R.S. Detection of human carcinogens. Nature 352 (1991) 185-186
14. LeBoeuf R.A., Kerckaert G.A., Aardema M.J., Gibson D.P., Brauninger R., and Isfort R.J. The pH 6.7 Syrian hamster embryo cell transformation assay for assessing the carcinogenic potential of chemicals. Mutat. Res. 356 (1996) 85-127
15. Tennant R.W., Margolin B.H., Shelby M.D., Zeiger E., Haseman J.K., Spalding J., Caspary W., Resnick M., Stasiewicz S., Anderson B., and Minor R. Prediction of chemical carcinogenicity in rodents from in vitro genotic toxicity assays. Science 236 (1987) 933-941
16. Zeiger E. Identification of rodent carcinogens and noncarcinogens using genetic toxicity tests: Premises, promises and performance. Regul. Toxicol. Pharmacol. 28 (1998) 85-95
17. Zeiger E. An interesting state of affairs in genetic toxicology. Environ. Mol. Mutagen. 35 (2000) 82-85
18. Zeiger E. Mutagens that are not carcinogens: faulty theory or faulty tests?. Mutat. Res. 492 (2001) 29-38
19. Lave L.B., Ennever F.K., Rosenkranz H.S., and Omenn G.S. Information value of the rodent bioassay. Nature 336 (1988) 631-633
20. Isfort R.J., Kerckaert G.A., and LeBoeuf R.A. Comparison of the standard and reduced pH Syrian Hamster embryo (SHE) cell in vitro transformation assays in predicting the carcinogenic potential of chemicals. Mutat. Res. 356 (1996) 11-63
21. Ames B.N., and Gold L.S. Too many rodent carcinogens: mitogenesis increases mutagenesis. Science 249 (1990) 970-971
22. Preston-Martin S., Pike M.C., Ross R.K., Jones P.A., and Henderson B.E. Increased cell division as a cause of human cancer. Cancer Res. 50 (1990) 7415-7421
23. Butterworth B.E. Consideration of both genotoxic and nongenotoxic mechanisms in predicting carcinogenic potential. Mutat. Res. 239 (1990) 117-132
24. Cohen S.M., and Ellwein L.B. Cell proliferation in carcinogenesis. Science 249 (1990) 1007-1011
25. Cohen S.M., and Ellwein L.B. Genetic errors, cell proliferation and carcinogenesis. Cancer Res. 51 (1991) 6493-6505
26. Chankong V., Haimes Y.Y., Rosenkranz H.S., and Pet-Edwards J. The carcinogenicity prediction and battery selection (CPBS) method: a Bayesian approach. Mutat. Res. 153 (1985) 135-166
27. Gold L.S., Slone T.H., and Ames B.N. Overview and update of analyses of the carcinogenic potency database. In: Gold L.S., and Zeiger E. (Eds). Handbook of Carcinogenic Potency and Genotoxicity Databases (1997), CRC Press, Boca Raton, FL 661-685
28. NTP, National Toxicology Program-Long Term Study Abstracts, 2003, http://ntp-server.niehs.nih.gov/htdocs/pub.html.
29. Ashby J., and Tennant R.W. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. Mutat. Res. 257 (1991) 229-306
30. Haimes Y.Y., Chankong V., Pet-Edwards J., and Rosenkranz H.S. Carcinogenicity prediction and battery selection procedure: an in depth analysis of cyclamate and its major metabolite cyclohexylamine. Mol. Toxicol. 1 (1987) 49-60
31. Rosenkranz H.S., and Ennever F.K. Quantifying genotoxicity and non-genotoxicity. Mutat. Res. 205 (1988) 59-67
32. Pet-Edwards J., Chankong V., Rosenkranz H.S., and Haimes Y.Y. Application of the carcinogenicity prediction and battery selection (CPBS) methodology to the Gene-Tox database. Mutat. Res. 153 (1985) 187-200
33. Sasaki Y.F., Sekihashi K., Izumiyama F., Nishidate E., Saga A., Ishida K., and Tsuda S. The Comet assay with multiple mouse organs: comparison of comet assay results and carcinogenicity with 208 chemicals selected from the IARC monographs and US NTP carcinogenicity database. Crit. Rev. Toxicol. 30 (2000) 629-799
34. Miller B., Pötter-Locher F., Seelbach A., Stopper H., Utesch D., and Madle S. Evaluation of the in vitro micronucleus test as an alternative to the in vitro chromosomal aberration assay: position of the GUM working group on the in vitro micronucleus test. Mutat. Res. 410 (1998) 81-116
35. Miller B., Albertini S., Locher F., Thybaud V., and Lorge E. Comparative evaluation of the in vitro micronucleus test and the in vitro chromosome aberration test: industrial experience. Mutat. Res. 392 (1997) 45-59
36. Matsushima T., Hayashi M., Matsuoka A., Ishidate Jr. M., Miura K.F., Shimizu H., Suzuki Y., Morimoto K., Ogura H., Mure K., Koshi K., and Sofuni T. Validation study of the in vitro micronucleus test in a Chinese hamster lung cell line (CHL/IU). Mutagenesis 14 (1999) 569-580
37. McKinney I.D., Richard A., Waller C., Newman M.C., and Gerberick F. The practice of structure-activity relationships (SAR) in toxicology. Toxicol. Sci. 56 (2000) 8-17
38. CEC, Commission of the European Communities, White Paper: Strategy for a Future Chemicals Policy, 2001, http://europa.eu.int./comm/environment/chemicals/whitepaper.htm.
39. Hulzebos E.M., and Posthumus R. (Q)SARS: gatekeepers against risk on chemicals?. SAR QSAR Environ. Res. 14 (2003) 285-316
40. Cronin M.T.D., Jaworska J.S., Walker J.D., Comber M.H.I., Watts C.D., and Worth A.P. Use of QSARs in international decision-making frameworks to predict health effects of chemical substances. Environ. Health Perspec. 111 (2003) 1391-1401
41. ECOTOC Workshop on Regulatory Acceptance of (Q)SARS for Human Health and Environmental Endpoints, European Centre for Ecotoxicology and Toxicology of Chemicals, March 4-6, 2002, http://www.ecetoc.org/, Setubal, Portugal, 2002.
42. J.D. Walker, R.H. Brink, New cost-effective, computerized approaches to selecting chemicals for priority testing consideration, in: G.W. Surer II, M.A. Lewis (Eds.), Aquatic Toxicology and Environmental Fate, ASTM STP 1007, 11, American Society for Testing and Materials, Philadelphia, 1989, pp. 507-536.
43. Jaworska J.S., Comber M., Auer C., and Van Leeuwen C.J. Summary of a workshop on regulatory acceptance of (Q)SARs for human health and environmental endpoints. Environ. Health Perspec. 111 (2003) 1358-1360
44. Eriksson L., Jaworska J., Worth A.P., Cronin M.T.D., McDowell R.M., and Gramatica P. Methods for reliability, uncertainty assessment, and for applicability evaluations of classification and regression based QSARs. Environ. Health Perspec. 111 (2003) 1361-1375
45. Rosenkranz H.S., Cunningham A.R., Zhang Y.P., Claycamp H.G., Macina O.T., Sussman N.B., Grant S.G., and Klopman G. Development, characterization and application of predictive-toxicology models. SAR QSAR Environ. Res. 10 (1999) 277-298
46. Matthews E.J., and Contrera J.F. A new highly specific method for predicting the carcinogenic potential of pharmaceuticals in rodents using enhanced MCASE QSAR-ES software. Regul. Toxicol. Pharmacol. 28 (1998) 242-264
47. Rosenkranz H.S. SAR in the assessment of carcinogenesis: the MULTICASE approach. In: Benigni R. (Ed). Quantitative Structure-Activity Relationship (QSAR) Models of Mutagens and Carcinogens (2003), CRC Press, LLC, Boca Raton, FL 175-206
48. Chung K.-T., Chen S.-C., Wong T.Y., Li Y.-S., Wei C.-I., and Chou M.W. Mutagenicity studies of benzidine and its analogs: structure-activity relationships. Toxicol. Sci. 56 (2000) 351-356
49. IARC, IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Suppl. 6, International Agency for Research on Cancer, Lyon, France, 1987.
50. Rosenkranz H.S., McCoy E.C., Sanders D.R., Butler M., Kiriazides D.K., and Mermelstein R. Nitropyrenes: isolation, identification and reduction of mutagenicimpurities in carbon black toners. Science 209 (1980) 1039-1043
51. Mermelstein R., Kiriazides D.K., Butler M., McCoy E.C., and Rosenkranz H.S. The extraordinary mutagenicity of nitropyrenes in bacteria. Mutat. Res. 89 (1981) 187-196